Drugs / PEHRG214
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00385567 | Jan 2007 → Sep 2008 | HIV infectious disease | Virionyx Corporation Limited | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEHRG214 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00385567 ↗ |
| Route | Intravenous | “PEHRG214 administered intravenously” NCT00385567 ↗ |